Corona Vaccine HIGHLIGHTS: 8 New Cases Of Mutant Covid Strain Detected In Maharashtra
Amid political controversies over the use of Bharat Biotech's COVAXIN, the company's MD Krishna Ella held a press conference citing that they do not belong to any political party and said that they are not just conducting clinical trials in India. We have done clinical trials more than 12 countries including UK and the vaccine is completely safe for the people. Stay tuned for latest updates
ABP News Bureau
Last Updated:
05 Jan 2021 12:03 AM
After 8 patients were found positive for the new Covid strain in Maharashtra, CM Uddhav Thackeray has decided to request the Centre to quarantine passengers arriving from the United Kingdom at other international airports in the country. It has been brought to the notice of govt that due to strict quarantine rules for UK returnees in Maharashtra, people returning from UK are taking flights to airports outside the state. Later they travel to Mumbai to avoid quarantine: Maharashtra Chief Minister's Office
After 8 patients were found positive for the new Covid strain in Maharashtra, CM Uddhav Thackeray has decided to request the Centre to quarantine passengers arriving from the United Kingdom at other international airports in the country. It has been brought to the notice of govt that due to strict quarantine rules for UK returnees in Maharashtra, people returning from UK are taking flights to airports outside the state. Later they travel to Mumbai to avoid quarantine: Maharashtra Chief Minister's Office
After 8 patients were found positive for the new Covid strain in Maharashtra, CM Uddhav Thackeray has decided to request the Centre to quarantine passengers arriving from the United Kingdom at other international airports in the country. It has been brought to the notice of govt that due to strict quarantine rules for UK returnees in Maharashtra, people returning from UK are taking flights to airports outside the state. Later they travel to Mumbai to avoid quarantine: Maharashtra Chief Minister's Office
It is a vaccine. It is not a backup. People should be responsible before making such statements: Bharat Biotech MD Krishna Ella on comments that Covaxin is a 'back-up vaccine'
It is a vaccine. It is not a backup. People should be responsible before making such statements: Bharat Biotech MD Krishna Ella on comments that Covaxin is a 'back-up vaccine'
Approval of COVAXIN for emergency use is a giant leap for innovation & novel product development in India. It is a proud moment for the nation & a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India: Bharat Biotech MD Krishna Ella
To control the spread of this mutated variant of the virus, authorities have started comprehensive contact tracing for co-travelers, family contacts, and others.
The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG labs," the Union health ministry had said last week.
The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG labs," the Union health ministry had said last week.
The number of people infected by the new mutated strain of Covid-19 in India has now reached 38. On Friday, January 1, the number stood at 29.
A total of 38 samples have been found to be positive with the new UK Covid-19 variant.
Of the 38 cases of the mutant strain, 10 have been detected at NIMHANS Bengaluru, three at CCMB Hyderabad, five at NIV Pune, 11 at IGIB Delhi, eight at in NCDC Delhi, and one at NCBG Kolkata.
A total of 38 samples have been found to be positive with the new UK Covid-19 variant.
Of the 38 cases of the mutant strain, 10 have been detected at NIMHANS Bengaluru, three at CCMB Hyderabad, five at NIV Pune, 11 at IGIB Delhi, eight at in NCDC Delhi, and one at NCBG Kolkata.
Tharoor criticises govt nod to Bharat Biotech vax without phase-3 trials
Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech's Covid vaccine without phase-3 trials.
The central licensing authority has granted permission to Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.
Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech's Covid vaccine without phase-3 trials.
The central licensing authority has granted permission to Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.
1.60 lakh health workers will be first to get COVID-19 vaccine in Punjab: Minister
(PTI)
Around 1.60 lakh health workers in Punjab will receive a COVID-19 vaccine in the first phase, Health Minister Balbir Singh Sidhu said on Sunday.
Principal Secretary (Health) Hussan Lal said the data regarding 1.60 lakh healthcare workers has already been uploaded on the CoWin portal -- an online platform for monitoring the delivery of COVID-19 vaccine.
Talking to reporters, Sidhu said, "...the vaccine which is coming will first be given to 1.60 lakh healthcare workers in the state."
Giving details of the vaccination process, Lal said the vaccine will be given to about 70 lakh people in the state in a phased manner.
(PTI)
Around 1.60 lakh health workers in Punjab will receive a COVID-19 vaccine in the first phase, Health Minister Balbir Singh Sidhu said on Sunday.
Principal Secretary (Health) Hussan Lal said the data regarding 1.60 lakh healthcare workers has already been uploaded on the CoWin portal -- an online platform for monitoring the delivery of COVID-19 vaccine.
Talking to reporters, Sidhu said, "...the vaccine which is coming will first be given to 1.60 lakh healthcare workers in the state."
Giving details of the vaccination process, Lal said the vaccine will be given to about 70 lakh people in the state in a phased manner.
India bars virus vaccine maker from exporting
India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday.
(AP)
India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday.
(AP)
How to self-register on CoWIN App for COVID-19 vaccination in India?
Step 1: In order to register on CoWIN, the user would need to download the CoWIN app from Google play store or the Apple app store.
Step 2: After downloading the application, you would upload your photo identity documents for self-registration process.
Step 3: Upload government photo identity or do an AADHAAR authentication. The authentication can happen via biometrics, OTP or demographic.
Step 4: Once registered, date and time will be allocated for vaccination. You will get a reminder SMS to reach on the allotted date and time for vaccination.
Step 5: In case you are not prepared to take the vaccine shot on the day you get an appointment, you can reschedule your visit to the vaccine booths.
Step 1: In order to register on CoWIN, the user would need to download the CoWIN app from Google play store or the Apple app store.
Step 2: After downloading the application, you would upload your photo identity documents for self-registration process.
Step 3: Upload government photo identity or do an AADHAAR authentication. The authentication can happen via biometrics, OTP or demographic.
Step 4: Once registered, date and time will be allocated for vaccination. You will get a reminder SMS to reach on the allotted date and time for vaccination.
Step 5: In case you are not prepared to take the vaccine shot on the day you get an appointment, you can reschedule your visit to the vaccine booths.
What Is CoWIN?
Ministry of Health and Family Welfare (MoHFW) along with Ministry of Electronics and Information Technology (MeitY) in December 2020 announced to launch “CoWIN”, a Grand Challenge for strengthening the COVID Vaccine Intelligence Network (CoWIN) system.
It is an upgraded version of the eVIN (Electronic Vaccine Intelligence Network), a digitalised platform to be used to effectively roll out and scale up the mechanism for COVID Vaccine Distribution System, nationally.
As explained by the government, the specially designed CoWIN app comes with five modules, namely - Administrator module, Registration module, Vaccination module, Beneficiary Acknowledgement module, and Report module.
As of now, the application is in the pre-product stage which can not be accessed by people, there is no self-registration going on. Once launched, it will be available to download for free via the Google Play Store and Apple App Store.
Ministry of Health and Family Welfare (MoHFW) along with Ministry of Electronics and Information Technology (MeitY) in December 2020 announced to launch “CoWIN”, a Grand Challenge for strengthening the COVID Vaccine Intelligence Network (CoWIN) system.
It is an upgraded version of the eVIN (Electronic Vaccine Intelligence Network), a digitalised platform to be used to effectively roll out and scale up the mechanism for COVID Vaccine Distribution System, nationally.
As explained by the government, the specially designed CoWIN app comes with five modules, namely - Administrator module, Registration module, Vaccination module, Beneficiary Acknowledgement module, and Report module.
As of now, the application is in the pre-product stage which can not be accessed by people, there is no self-registration going on. Once launched, it will be available to download for free via the Google Play Store and Apple App Store.
I am of the opinion that masks will probably be the last to go & probably may never even go: Dr Balram Bhargava, DG Indian Council of Medical Research (ICMR)
We don't know how long vaccine is going to effective, we don't know how much of the population we will have to vaccinate to break the virus transmission. What we know is that we've been able to control the pandemic in the country by following COVID appropriate behaviour: Dr Balram Bhargava, DG Indian Council of Medical Research (ICMR)
ICMR and Bharat Biotech collaborative a whole Virion Inactivated Corona Virus Vaccine (COVAXIN) is being approved for restricted use in an emergency by Drugs Controller General of India (DCGI): Indian Council of Medical Research (ICMR)
Initially, Serum Institute vaccine will be given. They already have 50 million doses available and they'll be able to give that in initial phase where we'll vaccinate around 3 Crore peopl. Gradually, we'll build on it and by the time Bharat Biotech data will also be available: AIIMS Director
Approval clearly says 'emergency situation' keeping in mind the circulating variant strains & at the same time, they have to continue the trial & get the data in. Once that data comes in, we'll be more confident as far as safety and efficacy is concerned: Dr. Randeep Guleria, AIIMS Director
In an emergency situation when there is a sudden increase in cases & we need to vaccinate, Bharat Biotech vaccine will be used. It can also be used as a backup when we're not sure how efficacious the Serum Institute vaccine is going to be: Dr Randeep Guleria, AIIMS Director
The Drugs Controller General of India (DCGI) on Sunday gave emergency-use approval to COVISHIELD, India’s home-grown coronavirus vaccine, and the other by AstraZeneca and Oxford University. Soon after the announcement on vaccines, the CEO of Serum Institute of India, Adar Poonawalla, wished a "Happy new year" to the people of the country.
The Drugs Controller General of India (DCGI) on Sunday gave emergency-use approval to COVISHIELD, India’s home-grown coronavirus vaccine, and the other by AstraZeneca and Oxford University. Soon after the announcement on vaccines, the CEO of Serum Institute of India, Adar Poonawalla, wished a "Happy new year" to the people of the country.
It's a great day for our country and it's a very good way to start the new year. Both the vaccines are made in India. They are cost-effective & easy to administer. We should, in a very short period, start rolling out vaccine: Dr Randeep Guleria, Director, AIIMS Delhi
Not getting vaccinated is an appeasement policy: Narottam Mishra
The Madhya Pradesh Minister said, " We can't even call him a misled youth. When he never listened to his uncle or father,why would he listen to the country? This is a policy of appeasement. It's not good to spread rumour about vaccine."
The Madhya Pradesh Minister said, " We can't even call him a misled youth. When he never listened to his uncle or father,why would he listen to the country? This is a policy of appeasement. It's not good to spread rumour about vaccine."
Not getting vaccinated is an appeasement policy: Narottam Mishra
The Madhya Pradesh Minister said, " We can't even call him a misled youth. When he never listened to his uncle or father,why would he listen to the country? This is a policy of appeasement. It's not good to spread rumour about vaccine."
The Madhya Pradesh Minister said, " We can't even call him a misled youth. When he never listened to his uncle or father,why would he listen to the country? This is a policy of appeasement. It's not good to spread rumour about vaccine."
"These vaccines are a fitting tribute to our corona warriors! My heartfelt gratitude to all healthcare professionals & frontline workers for their exemplary efforts during these unprecedented times. Congratulations to all the scientists & researchers for their untiring efforts," Dr. Harshvardhan said.
Ready to Roll Out COVID-19 Vaccine in India: Serum
Serum Institute of India (SII) on Sunday said it is ready to roll out Covishield vaccine in the country in the coming weeks after receiving approval from the Indian drug regulator. The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. On Sunday, Drug Controller General of India (DCGI) approved Covishield and Bharat Biotech's Covaxin for restricted emergency use.
Serum Institute of India (SII) on Sunday said it is ready to roll out Covishield vaccine in the country in the coming weeks after receiving approval from the Indian drug regulator. The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. On Sunday, Drug Controller General of India (DCGI) approved Covishield and Bharat Biotech's Covaxin for restricted emergency use.
Delhi Health Minister Satyendar Jain shares plans of Vaccine distribution
In the first phase, healthcare workers & frontline workers will be vaccinated. There are three lakh healthcare workers & six lakh frontline workers in Delhi who will be administered with the COVID vaccine: Delhi Health Minister Satyendar Jain
In the first phase, healthcare workers & frontline workers will be vaccinated. There are three lakh healthcare workers & six lakh frontline workers in Delhi who will be administered with the COVID vaccine: Delhi Health Minister Satyendar Jain
Delhi Health Minister Satyendar Jain shares plans of Vaccine distribution
In the first phase, healthcare workers & frontline workers will be vaccinated. There are three lakh healthcare workers & six lakh frontline workers in Delhi who will be administered with the COVID vaccine: Delhi Health Minister Satyendar Jain
In the first phase, healthcare workers & frontline workers will be vaccinated. There are three lakh healthcare workers & six lakh frontline workers in Delhi who will be administered with the COVID vaccine: Delhi Health Minister Satyendar Jain
Congress MP Shashi Tharoor Says 'Covaxin's Approval is Premature', Calls for Health Minister's Clarification.
The opposition has been attacking the centre on seeking emergency use authorization of Covid vaccine. Senior Congress leader has questioned the emergency use approval of Bharat Biotech's Covaxin and said that it is still under third phase trials so can't be used for distribution. Tharoor has sought clarification from the Health minister.
Meanwhile, SP Chief Akhilesh Yadav also said that he will not take shots of the 'BJP Vaccine' as he does not trust them.
The opposition has been attacking the centre on seeking emergency use authorization of Covid vaccine. Senior Congress leader has questioned the emergency use approval of Bharat Biotech's Covaxin and said that it is still under third phase trials so can't be used for distribution. Tharoor has sought clarification from the Health minister.
Meanwhile, SP Chief Akhilesh Yadav also said that he will not take shots of the 'BJP Vaccine' as he does not trust them.
Congress MP Shashi Tharoor Says 'Covaxin's Approval is Premature', Calls for Health Minister's Clarification.
The opposition has been attacking the centre on seeking emergency use authorization of Covid vaccine. Senior Congress leader has questioned the emergency use approval of Bharat Biotech's Covaxin and said that it is still under third phase trials so can't be used for distribution. Tharoor has sought clarification from the Health minister.
Meanwhile, SP Chief Akhilesh Yadav also said that he will not take shots of the 'BJP Vaccine' as he does not trust them.
The opposition has been attacking the centre on seeking emergency use authorization of Covid vaccine. Senior Congress leader has questioned the emergency use approval of Bharat Biotech's Covaxin and said that it is still under third phase trials so can't be used for distribution. Tharoor has sought clarification from the Health minister.
Meanwhile, SP Chief Akhilesh Yadav also said that he will not take shots of the 'BJP Vaccine' as he does not trust them.
WHO Welcomes First Emergency Vaccine
“WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. This decision taken today by India will help intensify and strengthen the fight against COVID-19 pandemic in the Region. The use of vaccine in prioritized populations, along with the continued implementation of other public health measures and community participation will be important in reducing the impact of COVID-19" - Dr. Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region
“WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. This decision taken today by India will help intensify and strengthen the fight against COVID-19 pandemic in the Region. The use of vaccine in prioritized populations, along with the continued implementation of other public health measures and community participation will be important in reducing the impact of COVID-19" - Dr. Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region
DCGI refutes claims by Akhilesh Yadav's MLC of people becoming impotent by Covid vaccine
We'll never approve anything if there's slightest of safety concern. Vaccines are 110 % safe. Some side effects like mild fever, pain & allergy are common for every vaccine. It (that people may get impotent) is absolute rubbish: VG Somani, Drug Controller General of India
DCGI refutes claims by Akhilesh Yadav's MLC of people becoming impotent by Covid vaccine
We'll never approve anything if there's slightest of safety concern. Vaccines are 110 % safe. Some side effects like mild fever, pain & allergy are common for every vaccine. It (that people may get impotent) is absolute rubbish: VG Somani, Drug Controller General of India
PM Modi lauds the Aatmanirbhar spirit after India gets Covid vaccine
PM Modi took to twitter and said, "A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of
Serum Institute of India and Bharat Biotech
accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
PM Modi took to twitter and said, "A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of
Serum Institute of India and Bharat Biotech
accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
PM Modi lauds the Aatmanirbhar spirit after India gets Covid vaccine
PM Modi took to twitter and said, "A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of
Serum Institute of India and Bharat Biotech
accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
PM Modi took to twitter and said, "A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of
Serum Institute of India and Bharat Biotech
accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
PM Modi tweets and congratulates Indian Citizens after DCGI officially approved vaccines by Bharat Biotech and Oxford
PM Modi tweets and congratulates Indian Citizens after DCGI officially approved vaccines by Bharat Biotech and Oxford
Covid-19 vaccines- COVAXIN and COVISHIELD have been cleared by the DCGI, V G Somani. "The vaccines will be administered in two dosages and Cadila will have three dosages," Somani added.
The DCGI has approved Bharat Biotech's Covaxin and Oxford's Covishield for emergency use authorisation. DCGI has also approved phase 3 trials for Cadila Healthcare vaccine
DCGI addresses press conference on Covid vaccine.DCGI is likely to give the final nod on Bharat Biotech and Ocford vaccine.
Bharat Biotech has successfully recruited 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple sites in India, it said.
The vaccination drive has been based on the election process planned down to the booth level. Over 57,000 participants across 719 districts have completed training, 96,000 vaccinators have been trained so far, said Union Health Minister Dr Harsh Vardhan
India reports 18,177 new COVID-19 cases, 20,923 recoveries, and 217 deaths in last 24 hours, as per Union Health Ministry. So far the total cases have reached 1,03,23,965, Active cases are at 2,47,220, total recoveries are- 99,27,310, while the death toll crossed 1,49,435
Background
The chief of India’s drugs regulator will address a press conference on Sunday, a day after its experts recommended that the Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease (Covid-19) be allowed for emergency use in the country, reports have said. The Drugs Controller General of India (DCGI) will speak at 11 am and is likely to announce the approval of 2 vaccines.
Also Read| Just One Step Away From Covid Vaccine, Health Minister Informs How Co-Win Will Facilitate Inoculation
The country’s top drug regulator had indicated earlier this week that India is likely to get a vaccine against Covid-19 in the New Year. “We will have a Happy New Year with something in hand, that’s all I can hint at,” VG Somani, DCGI, had said on Thursday.
If DCGI grants his nod, India will be among a handful of countries, including the US and UK, that have begun vaccinations. Both the US and the UK too have approved two vaccines, but in their case, all of the candidates have completed the requisite scientific process.
India conducted a massive dry run for vaccination across the country on Saturday and Union Health Minister appealed to people not to be misguided by "rumours" regarding the safety and efficacy of the coronavirus vaccine, and said the most prioritised beneficiaries would be vaccinated for free. Vardhan stressed that there would be no compromise on any protocol while approving the vaccine.
He added that details were being finalised about how 27 crore priority beneficiaries -- those above 50 years of age and those below it having comorbidities -- would be vaccinated until July.
The minister dispelled doubts regarding the country's capability to undertake such a massive vaccination drive, describing how India had unparalleled experience in dealing with immunisation and runs one of the largest such programmes in the world.
- - - - - - - - - Advertisement - - - - - - - - -